GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Gross-Profit-to-Asset %

BML (BMLKF) Gross-Profit-to-Asset % : 28.06% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is BML Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. BML's annualized Gross Profit for the quarter that ended in Dec. 2023 was $323.4 Mil. BML's average Total Assets over the quarter that ended in Dec. 2023 was $1,152.8 Mil. Therefore, BML's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 28.06%.

BML Gross-Profit-to-Asset % Historical Data

The historical data trend for BML's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Gross-Profit-to-Asset % Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.96 42.69 52.53 33.13 25.32

BML Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.06 27.93 26.86 28.06 24.06

Competitive Comparison of BML's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, BML's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BML's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where BML's Gross-Profit-to-Asset % falls into.


BML Gross-Profit-to-Asset % Calculation

BML's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=304.555/( (1263.935+1141.32)/ 2 )
=304.555/1202.6275
=25.32 %

BML's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=323.432/( (1141.594+1163.92)/ 2 )
=323.432/1152.757
=28.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

BML Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of BML's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

BML (BMLKF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (OTCPK:BMLKF) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
TSE:4544 TSE:2395 TSE:2309 TSE:4671 TSE:7707 TSE:3386 TSE:2397 TSE:6090 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
4694:Japan
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
Website
http://www.bml.co.jp
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.